Market Place
Sourcing Support
FDA`s vaccine adcomm to review 1st fecal transplant for C. difficile infections
08 Aug 2022 //
ENDPTS
Ferring presents data from five trials of RBX2660 demonstrating uniform efficacy
29 Sep 2021 //
BUSINESSWIRE
Ferring and Rebiotix to Present Landmark Data for Investigational Microbiota
13 May 2021 //
PRESS RELEASE
Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based
16 Feb 2021 //
BUSINESSWIRE
After big 2016 setback, field of microbiome-based drugs gets injection promise
06 May 2020 //
ENDPTS
Rebiotix & Ferring Announce World’s First With Positive Pivotal Ph3 Data RBX2660
06 May 2020 //
BUSINESSWIRE
Rebiotix, a Ferring Company, Completes Enrollment, Pivotal Ph 3 Trial RBX2660
05 Feb 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.